These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
379 related articles for article (PubMed ID: 26597367)
1. Clinicopathologic and Prognostic Features in Patients with Peritoneal Metastasis from Mucinous Adenocarcinoma, Adenocarcinoma with Signet Ring Cells, and Adenocarcinoid of the Appendix Treated with Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy. Ihemelandu C; Sugarbaker PH Ann Surg Oncol; 2016 May; 23(5):1474-80. PubMed ID: 26597367 [TBL] [Abstract][Full Text] [Related]
2. Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Jimenez W; Sardi A; Nieroda C; Sittig M; Milovanov V; Nunez M; Aydin N; Gushchin V Ann Surg Oncol; 2014 Dec; 21(13):4218-25. PubMed ID: 24986239 [TBL] [Abstract][Full Text] [Related]
3. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504 [TBL] [Abstract][Full Text] [Related]
4. Sites of Recurrence After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis from Colorectal and Appendiceal Adenocarcinoma: A Tertiary Center Experience. Feferman Y; Solomon D; Bhagwandin S; Kim J; Aycart SN; Feingold D; Sarpel U; Labow DM Ann Surg Oncol; 2019 Feb; 26(2):482-489. PubMed ID: 30539491 [TBL] [Abstract][Full Text] [Related]
5. Systemic chemotherapy (SC) before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with peritoneal mucinous carcinomatosis of appendiceal origin (PMCA). Milovanov V; Sardi A; Ledakis P; Aydin N; Nieroda C; Sittig M; Nunez M; Gushchin V Eur J Surg Oncol; 2015 May; 41(5):707-12. PubMed ID: 25633641 [TBL] [Abstract][Full Text] [Related]
6. The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis. El Halabi H; Gushchin V; Francis J; Athas N; Macdonald R; Nieroda C; Studeman K; Sardi A Ann Surg Oncol; 2012 Jan; 19(1):110-4. PubMed ID: 21701929 [TBL] [Abstract][Full Text] [Related]
7. Systemic chemotherapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade mucinous carcinoma peritonei of appendiceal origin. Munoz-Zuluaga CA; King MC; Ledakis P; Gushchin V; Sittig M; Nieroda C; Zambrano-Vera K; Sardi A Eur J Surg Oncol; 2019 Sep; 45(9):1598-1606. PubMed ID: 31109821 [TBL] [Abstract][Full Text] [Related]
8. Outcomes in Peritoneal Dissemination from Signet Ring Cell Carcinoma of the Appendix Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Munoz-Zuluaga C; Sardi A; King MC; Nieroda C; Sittig M; MacDonald R; Gushchin V Ann Surg Oncol; 2019 Feb; 26(2):473-481. PubMed ID: 30523470 [TBL] [Abstract][Full Text] [Related]
9. The 7th Edition of the AJCC Staging Classification Correlates with Biologic Behavior of Mucinous Appendiceal Tumor with Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC). Milovanov V; Sardi A; Studeman K; Nieroda C; Sittig M; Gushchin V Ann Surg Oncol; 2016 Jun; 23(6):1928-33. PubMed ID: 26714951 [TBL] [Abstract][Full Text] [Related]
10. Adverse Events Postoperatively Had No Impact on Long-Term Survival of Patients Treated with Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy for Appendiceal Cancer with Peritoneal Metastases. Ihemelandu C; Mavros MN; Sugarbaker P Ann Surg Oncol; 2016 Dec; 23(13):4231-4237. PubMed ID: 27338748 [TBL] [Abstract][Full Text] [Related]
11. Histological Subtype Remains a Significant Prognostic Factor for Survival Outcomes in Patients With Appendiceal Mucinous Neoplasm With Peritoneal Dissemination. Huang Y; Alzahrani NA; Chua TC; Morris DL Dis Colon Rectum; 2017 Apr; 60(4):360-367. PubMed ID: 28267002 [TBL] [Abstract][Full Text] [Related]
12. [Prognostic value of clinical and pathological characteristics in 48 women with pseudomyxoma peritonei]. Lu YY; Guo AT; Liu AJ; Shi HY Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):595-601. PubMed ID: 24199925 [TBL] [Abstract][Full Text] [Related]
13. Long term survival analysis after hyperthermic intraperitoneal chemotherapy with oxaliplatin as a treatment for appendiceal peritoneal carcinomatosis. Masckauchan D; Trabulsi N; Dubé P; Aubé-Lecompte ME; Cloutier AS; Mitchell A; Sideris L Surg Oncol; 2019 Mar; 28():69-75. PubMed ID: 30851915 [TBL] [Abstract][Full Text] [Related]
14. A Prognostic Model for Predicting Overall Survival in Patients with Peritoneal Surface Malignancy of an Appendiceal Origin Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Ihemelandu C; Fernandez S; Sugarbaker PH Ann Surg Oncol; 2017 Aug; 24(8):2266-2272. PubMed ID: 28342015 [TBL] [Abstract][Full Text] [Related]
15. Prolonged Survival in Peritoneal Metastatic Appendiceal Carcinoma Patients Treated With Combined Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Acs M; Gerken M; Zustin J; Blaj S; Isgandarova S; Piso P J Surg Res; 2023 Mar; 283():839-852. PubMed ID: 36915011 [TBL] [Abstract][Full Text] [Related]
16. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Moderately and Poorly Differentiated Appendiceal Adenocarcinoma: Survival Outcomes and Patient Selection. Grotz TE; Overman MJ; Eng C; Raghav KP; Royal RE; Mansfield PF; Mann GN; Robinson KA; Beaty KA; Rafeeq S; Matamoros A; Taggart MW; Fournier KF Ann Surg Oncol; 2017 Sep; 24(9):2646-2654. PubMed ID: 28695394 [TBL] [Abstract][Full Text] [Related]
17. Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer. de Cuba EM; de Hingh IH; Sluiter NR; Kwakman R; Coupé VM; Beliën JA; Verwaal VJ; Meijerink WJ; Delis-van Diemen PM; Bonjer HJ; Meijer GA; Te Velde EA Ann Surg Oncol; 2016 May; 23(5):1601-8. PubMed ID: 26727921 [TBL] [Abstract][Full Text] [Related]
18. Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Patients with High-Grade, High-Volume Disseminated Mucinous Appendiceal Neoplasms. Polanco PM; Ding Y; Knox JM; Ramalingam L; Jones H; Hogg ME; Zureikat AH; Holtzman MP; Pingpank J; Ahrendt S; Zeh HJ; Bartlett DL; Choudry HA Ann Surg Oncol; 2016 Feb; 23(2):382-90. PubMed ID: 26429720 [TBL] [Abstract][Full Text] [Related]
19. Selection and Characteristics of Patients with Peritoneal Dissemination from Appendiceal Cancer with Exceptional/Poor Survival After CRS/HIPEC. Munoz-Zuluaga C; King MC; Sardi A; Ledakis P; Sittig M; Nieroda C; MacDonald R; Gushchin V Ann Surg Oncol; 2019 Jul; 26(7):2268-2275. PubMed ID: 31041628 [TBL] [Abstract][Full Text] [Related]
20. Extensive surgical history prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is associated with poor survival outcomes in patients with peritoneal mucinous carcinomatosis of appendiceal origin. Milovanov V; Sardi A; Aydin N; Nieroda C; Sittig M; Nunez M; Gushchin V Eur J Surg Oncol; 2015 Jul; 41(7):881-5. PubMed ID: 25899982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]